Ownership

David Lamond - Director at Quince Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: Director
Stock Symbol: QNCX on Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
All Insider Reports: All Insider Reports

David Lamond - trading volume in the past year for Quince Therapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys	+168K	100%	$1.00	+$168K
Sells
Net	+168K	100%		+$168K

Holdings reported by David Lamond for Quince Therapeutics, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	2.35M	$2.21M	$0.94	Dec 14, 2023	By Blue Devil Trust dated 12/03/2010
Common Stock	2.3M	$2.16M	$0.94	Dec 12, 2023	Direct
Common Stock	1.73M	$1.63M	$0.94	Dec 12, 2023	By David A. Lamond Trust dated 2006
Employee Stock Option (right to buy)	27K			Jun 5, 2024	Direct	Common Stock

Transactions reported by David Lamond for Quince Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.